I can not believe the market has got this stock right.
Sure, it is expanding with new acquisitions. It is consolidating a fractured market in medical instruments and supplies, so the opportunities are huge. Sure, the results are uncertain. But it has already reported 7% organic growth +acquisitions and cross-selling. A Hong Kong company has brought 15% of the company at 89 cents per share. This wil fund further expansion. Its cash flow will be impressive. The market price is 68 cents! (30% difference). Analysts est 7.1c earnings FY19 (fPE <10).
This company had its first profitable seven or eight years ago, and it keeps growing. With the new entrant, the company will be soon be captialised over $300m, making it eligible for the ASX200. That means other analysts will follow, and it will move into the highly traded.
I see this stock over $1 ps within twelve months. That's 40% return.
What do you think?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $629.0M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 38.0¢ | $26.18K | 68.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 314858 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 28545 | 1 |
View Market Depth
| Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
| PGC (ASX) Chart |